Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Forums: Live Discussions
Live Discussions

Updated 5 March 2007

ADCS Prevention Instrument Project


Steven Ferris

Peter J. Whitehouse

Lon Schneider

Marian Patterson

David Salmon

Doug Galasko
There is now a concerted push in the research community to find pharmacological and/or non-pharmacological interventions that can prevent or slow the progression of Alzheimer disease. But prevention trials promise to be long and potentially costly affairs. In a supplement in the October-December 2006 Alzheimer Disease and Associated Disorders, Steven Ferris and colleagues outlined the bones of the Alzheimer’s Disease Cooperative Study (ADCS) Prevention Instrument Project, which addresses the cost and burden associated with AD prevention trials.
View Presentation
You will need Windows Media Player (PC Mac) to view this presentation.

Steven Ferris, Doug Galasko, Marian Patterson, David Salmon, Mary Sano, Lon Schneider, Peter Whitehouse, and colleagues led this Webinar on 12 March 2007. Readers are invited to submit additional comments by using our Comments form at the bottom of the page.


Background Text
By Tom Fagan

There is now a concerted push in the research community to find interventions that can prevent or slow the progression of Alzheimer disease. But because AD develops so slowly in most people, and affects only a minority of people under the age of 85, prevention trials are bound to be large, long, and costly affairs. Part of that cost will be consumed by regular cognitive testing, currently an expensive procedure. Some of these tests also place considerable strain on trial volunteers, threatening to limit recruitment and increase dropout rate. In a supplement in the October-December 2006 Alzheimer Disease and Associated Disorders, Steven Ferris and colleagues outlined the Alzheimer’s Disease Cooperative Study (ADCS) Prevention Instrument Project, which addresses the need to reduce the burden and cost of prevention trials. The ADCS PI Project is currently evaluating instruments that could be used for home-based assessment during clinical trials. The premise is that such home-based instruments, conducted via phone or through questionnaire, should be considerably cheaper than clinic-based assessments and should also be less burdensome on patients, caregivers, and clinical staff.

The supplement addresses instruments for assessing six domains: cognition, behavior, activities of daily living, global change, quality of life, and resource use. In this live Webinar, Steven Ferris, Doug Galasko, Marian Patterson, David Salmon, Mary Sano, Lon Schneider, Peter Whitehouse, and colleagues gave an overview of the Prevention Instrument Project. Some of the topics covered in the supplement and up for discussion were

  • Assessment of Instrumental Activities of Daily Living for Community-dwelling Elderly Individuals in Dementia Prevention Clinical Trials
  • ADCS-Clinicians’ Global Impression of Change Scales (ADCS-CGIC), Self-rated and Study Partner-rated Versions
  • Development of a Brief Verbal Memory Test for Primary Prevention Clinical Trials
  • Behavioral Measures in Primary Prevention Trials
  • The Mail-in Cognitive Function Screening Instrument (MCFSI)
  • Quality of Life Assessment (QOL)
  • Pharmacoeconomics: Assessing Health-related Resource Use Among Healthy Elderly
  • Pilot Testing of a Book Club as a Psychosocial Intervention and Recruitment and Retention Strategy


Alzforum is extremely grateful to Lippincott, Williams and Wilkins for allowing us to reproduce graphs and figures that appeared in the October-December 2006 supplement.



  Submit a Comment on this Live Discussion
Cast your vote and/or make a comment on this live discussion. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
 


Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Live Discussion FAQs

Webinar: A Webinar is a seminar conducted remotely over the Web. Attendees view the slides through their Web browser and hear the presentations over their own telephones.

Registration: All participants are to register by clicking on the "Register for the Webinar" link.

Access: After you register, you will receive an e-mail with a link to the Webinar and a phone number.

View Webinar Instructions

Early Detection Survey Results
The Alzheimer Disease Early Detection Surveys were designed to gauge perceptions and knowledge of early detection of Alzheimer disease as a follow-up to our Early Detection Webinar. The surveys were developed in collaboration with the Geoffrey Beene Foundation.
View Researcher Survey Results [.pdf].
View Public Survey Results [.pdf].
AlzPossible Initiative
The AlzPossible Initiative is an innovative "center without walls" that enables skilled individuals to share their knowledge about best practices in Alzheimer caregiving through this open forum.
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad